ID   IMDH_ECOLI              Reviewed;         488 AA.
AC   P0ADG7; P06981; P76574; P78202;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 1.
DT   15-FEB-2017, entry version 102.
DE   RecName: Full=Inosine-5'-monophosphate dehydrogenase {ECO:0000255|HAMAP-Rule:MF_01964};
DE            Short=IMP dehydrogenase {ECO:0000255|HAMAP-Rule:MF_01964};
DE            Short=IMPD {ECO:0000255|HAMAP-Rule:MF_01964};
DE            Short=IMPDH {ECO:0000255|HAMAP-Rule:MF_01964};
DE            EC=1.1.1.205 {ECO:0000255|HAMAP-Rule:MF_01964};
GN   Name=guaB {ECO:0000255|HAMAP-Rule:MF_01964}; Synonyms=guaR;
GN   OrderedLocusNames=b2508, JW5401;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=2860637; DOI=10.1093/nar/13.4.1303;
RA   Tiedeman A.A., Smith J.M.;
RT   "Nucleotide sequence of the guaB locus encoding IMP dehydrogenase of
RT   Escherichia coli K12.";
RL   Nucleic Acids Res. 13:1303-1316(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-96.
RX   PubMed=2998937; DOI=10.1016/0378-1119(85)90068-X;
RA   Thomas M.S., Drabble W.T.;
RT   "Nucleotide sequence and organisation of the gua promoter region of
RT   Escherichia coli.";
RL   Gene 36:45-53(1985).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-90.
RX   PubMed=1736096;
RA   Tesfa-Selase F., Drabble W.T.;
RT   "Regulation of the gua operon of Escherichia coli by the DnaA
RT   protein.";
RL   Mol. Gen. Genet. 231:256-264(1992).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-12.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [8]
RP   PARTIAL PROTEIN SEQUENCE OF 1-11.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Frutiger S., Hughes G.J., Pasquali C., Hochstrasser D.F.;
RL   Submitted (FEB-1996) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 1-5.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9629924; DOI=10.1002/elps.1150190539;
RA   Molloy M.P., Herbert B.R., Walsh B.J., Tyler M.I., Traini M.,
RA   Sanchez J.-C., Hochstrasser D.F., Williams K.L., Gooley A.A.;
RT   "Extraction of membrane proteins by differential solubilization for
RT   separation using two-dimensional gel electrophoresis.";
RL   Electrophoresis 19:837-844(1998).
RN   [10]
RP   PROTEIN SEQUENCE OF 1-4.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9600841; DOI=10.1006/jmbi.1998.1726;
RA   Wilkins M.R., Gasteiger E., Tonella L., Ou K., Tyler M.,
RA   Sanchez J.-C., Gooley A.A., Walsh B.J., Bairoch A., Appel R.D.,
RA   Williams K.L., Hochstrasser D.F.;
RT   "Protein identification with N and C-terminal sequence tags in
RT   proteome projects.";
RL   J. Mol. Biol. 278:599-608(1998).
RN   [11]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, ENZYME REGULATION,
RP   AND MUTAGENESIS OF ASP-13; ASP-50; GLU-54; ASP-138; ASP-200; ASP-243;
RP   ASP-248; ASP-338; GLU-369; GLU-373 AND GLU-469.
RC   STRAIN=K12;
RX   PubMed=9341229; DOI=10.1021/bi9714161;
RA   Kerr K.M., Hedstrom L.;
RT   "The roles of conserved carboxylate residues in IMP dehydrogenase and
RT   identification of a transition state analog.";
RL   Biochemistry 36:13365-13373(1997).
RN   [12]
RP   DOMAIN CBS.
RC   STRAIN=K12 / BW25113;
RX   PubMed=18312263; DOI=10.1111/j.1365-2958.2008.06153.x;
RA   Pimkin M., Markham G.D.;
RT   "The CBS subdomain of inosine 5'-monophosphate dehydrogenase regulates
RT   purine nucleotide turnover.";
RL   Mol. Microbiol. 68:342-359(2008).
RN   [13]
RP   DOMAIN CBS.
RC   STRAIN=K12 / BW25113;
RX   PubMed=19153081; DOI=10.1074/jbc.M808541200;
RA   Pimkin M., Pimkina J., Markham G.D.;
RT   "A regulatory role of the Bateman domain of IMP dehydrogenase in
RT   adenylate nucleotide biosynthesis.";
RL   J. Biol. Chem. 284:7960-7969(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-267 AND LYS-428, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.M800187-MCP200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
CC   -!- FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP)
CC       to xanthosine 5'-phosphate (XMP), the first committed and rate-
CC       limiting step in the de novo synthesis of guanine nucleotides, and
CC       therefore plays an important role in the regulation of cell
CC       growth. {ECO:0000255|HAMAP-Rule:MF_01964,
CC       ECO:0000269|PubMed:9341229}.
CC   -!- CATALYTIC ACTIVITY: Inosine 5'-phosphate + NAD(+) + H(2)O =
CC       xanthosine 5'-phosphate + NADH. {ECO:0000255|HAMAP-Rule:MF_01964}.
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01964};
CC   -!- ENZYME REGULATION: Mycophenolic acid (MPA) is a non-competitive
CC       inhibitor that prevents formation of the closed enzyme
CC       conformation by binding to the same site as the amobile flap. In
CC       contrast, mizoribine monophosphate (MZP) is a competitive
CC       inhibitor that induces the closed conformation. MPA is a potent
CC       inhibitor of mammalian IMPDHs but a poor inhibitor of the
CC       bacterial enzymes. MZP is a more potent inhibitor of bacterial
CC       IMPDH. IMP dehydrogenase subunit of E.coli contains a cysteine at
CC       the IMP binding site and is inhibited in a simple competitive
CC       manner by GMP. It does not exhibit allosteric properties as does
CC       IMP dehydrogenase from B.subtilis or S.typhimurium.
CC       {ECO:0000255|HAMAP-Rule:MF_01964, ECO:0000269|PubMed:9341229}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=61 uM for Inosine 5'-phosphate {ECO:0000269|PubMed:9341229};
CC         KM=2000 uM for NAD(+) {ECO:0000269|PubMed:9341229};
CC         KM=2.8 mM for K(+) {ECO:0000269|PubMed:9341229};
CC   -!- PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway;
CC       XMP from IMP: step 1/1. {ECO:0000255|HAMAP-Rule:MF_01964}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_01964,
CC       ECO:0000269|PubMed:9341229}.
CC   -!- DOMAIN: The CBS domain of IMPDH is a negative trans-regulator of
CC       adenylate nucleotide synthesis, and this role is independent of
CC       the catalytic function of IMPDH in the de novo GMP biosynthesis.
CC       Deletion of the CBS domain derepresses the synthesis of AMP from
CC       IMP. {ECO:0000269|PubMed:18312263, ECO:0000269|PubMed:19153081}.
CC   -!- SIMILARITY: Belongs to the IMPDH/GMPR family. {ECO:0000255|HAMAP-
CC       Rule:MF_01964}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA26133.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X02209; CAA26133.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC75561.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16395.2; -; Genomic_DNA.
DR   EMBL; M10101; AAB18618.1; -; Genomic_DNA.
DR   PIR; C65027; DEECIP.
DR   RefSeq; NP_417003.1; NC_000913.3.
DR   RefSeq; WP_001299507.1; NZ_LN832404.1.
DR   ProteinModelPortal; P0ADG7; -.
DR   SMR; P0ADG7; -.
DR   BioGrid; 4263221; 63.
DR   BioGrid; 851324; 1.
DR   DIP; DIP-36207N; -.
DR   IntAct; P0ADG7; 1.
DR   MINT; MINT-1235980; -.
DR   STRING; 511145.b2508; -.
DR   BindingDB; P0ADG7; -.
DR   ChEMBL; CHEMBL3630; -.
DR   SWISS-2DPAGE; P0ADG7; -.
DR   EPD; P0ADG7; -.
DR   PaxDb; P0ADG7; -.
DR   PRIDE; P0ADG7; -.
DR   EnsemblBacteria; AAC75561; AAC75561; b2508.
DR   EnsemblBacteria; BAA16395; BAA16395; BAA16395.
DR   GeneID; 946985; -.
DR   KEGG; ecj:JW5401; -.
DR   KEGG; eco:b2508; -.
DR   PATRIC; 32120407; VBIEscCol129921_2606.
DR   EchoBASE; EB0416; -.
DR   EcoGene; EG10421; guaB.
DR   eggNOG; ENOG4105CP4; Bacteria.
DR   eggNOG; COG0516; LUCA.
DR   eggNOG; COG0517; LUCA.
DR   HOGENOM; HOG000165755; -.
DR   InParanoid; P0ADG7; -.
DR   KO; K00088; -.
DR   OMA; SSMGYCG; -.
DR   PhylomeDB; P0ADG7; -.
DR   BioCyc; EcoCyc:IMP-DEHYDROG-MONOMER; -.
DR   BioCyc; MetaCyc:IMP-DEHYDROG-MONOMER; -.
DR   UniPathway; UPA00601; UER00295.
DR   PRO; PR:P0ADG7; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0003938; F:IMP dehydrogenase activity; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006177; P:GMP biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006183; P:GTP biosynthetic process; IBA:GO_Central.
DR   CDD; cd00381; IMPDH; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_01964; IMPDH; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR005990; IMP_DH.
DR   InterPro; IPR015875; IMP_DH/GMP_Rdtase_CS.
DR   InterPro; IPR001093; IMP_DH_GMPRt.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00478; IMPDH; 1.
DR   PIRSF; PIRSF000130; IMPDH; 1.
DR   SMART; SM00116; CBS; 2.
DR   TIGRFAMs; TIGR01302; IMP_dehydrog; 1.
DR   PROSITE; PS51371; CBS; 2.
DR   PROSITE; PS00487; IMP_DH_GMP_RED; 1.
PE   1: Evidence at protein level;
KW   Acetylation; CBS domain; Complete proteome; Direct protein sequencing;
KW   GMP biosynthesis; Metal-binding; NAD; Oxidoreductase; Potassium;
KW   Purine biosynthesis; Reference proteome; Repeat.
FT   CHAIN         1    488       Inosine-5'-monophosphate dehydrogenase.
FT                                /FTId=PRO_0000093695.
FT   DOMAIN       93    149       CBS 1. {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   DOMAIN      153    214       CBS 2. {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   NP_BIND     248    250       NAD. {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   NP_BIND     298    300       NAD. {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   REGION      338    340       IMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01964}.
FT   REGION      361    362       IMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01964}.
FT   REGION      385    389       IMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01964}.
FT   ACT_SITE    305    305       Thioimidate intermediate.
FT                                {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   ACT_SITE    401    401       Proton acceptor. {ECO:0000255|HAMAP-
FT                                Rule:MF_01964}.
FT   METAL       300    300       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   METAL       302    302       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   METAL       305    305       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   METAL       469    469       Potassium; via carbonyl oxygen; shared
FT                                with tetrameric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   METAL       470    470       Potassium; via carbonyl oxygen; shared
FT                                with tetrameric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   METAL       471    471       Potassium; via carbonyl oxygen; shared
FT                                with tetrameric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   BINDING     248    248       NAD. {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   BINDING     303    303       IMP. {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   BINDING     415    415       IMP. {ECO:0000255|HAMAP-Rule:MF_01964}.
FT   MOD_RES     267    267       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18723842}.
FT   MOD_RES     428    428       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18723842}.
FT   MUTAGEN      13     13       D->A: Causes a 38-fold increase in the
FT                                value of Km for K(+). No change is
FT                                observed in the value of Km for IMP.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN      50     50       D->A: Causes a 17-fold increase in the
FT                                value of Km for K(+).
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN      54     54       E->A: No effect.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     138    138       D->A: No effect.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     200    200       D->A: No effect.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     243    243       D->A: No effect.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     248    248       D->A: Causes a 130-fold decrease in the
FT                                value of kcat.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     338    338       D->A: Decreases the value of kcat by 600-
FT                                fold. Increases the value of Km for IMP
FT                                by 12-fold. {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     369    369       E->A: No effect.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     373    373       E->A: No effect.
FT                                {ECO:0000269|PubMed:9341229}.
FT   MUTAGEN     469    469       E->A: Increases the value of Km for K(+)
FT                                by 17-fold. {ECO:0000269|PubMed:9341229}.
FT   CONFLICT    206    206       R -> A (in Ref. 1; CAA26133/AAB18618).
FT                                {ECO:0000305}.
SQ   SEQUENCE   488 AA;  52022 MW;  B0FD0A786779C98E CRC64;
     MLRIAKEALT FDDVLLVPAH STVLPNTADL STQLTKTIRL NIPMLSAAMD TVTEARLAIA
     LAQEGGIGFI HKNMSIERQA EEVRRVKKHE SGVVTDPQTV LPTTTLREVK ELTERNGFAG
     YPVVTEENEL VGIITGRDVR FVTDLNQPVS VYMTPKERLV TVREGEAREV VLAKMHEKRV
     EKALVVDDEF HLIGMITVKD FQKAERKPNA CKDEQGRLRV GAAVGAGAGN EERVDALVAA
     GVDVLLIDSS HGHSEGVLQR IRETRAKYPD LQIIGGNVAT AAGARALAEA GCSAVKVGIG
     PGSICTTRIV TGVGVPQITA VADAVEALEG TGIPVIADGG IRFSGDIAKA IAAGASAVMV
     GSMLAGTEES PGEIELYQGR SYKSYRGMGS LGAMSKGSSD RYFQSDNAAD KLVPEGIEGR
     VAYKGRLKEI IHQQMGGLRS CMGLTGCGTI DELRTKAEFV RISGAGIQES HVHDVTITKE
     SPNYRLGS
//
